These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 109592)

  • 1. Further characterization of responses of infants and children to meningococcal A polysaccharide vaccine.
    Wilkins J; Wehrle PF
    J Pediatr; 1979 May; 94(5):828-32. PubMed ID: 109592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses of human infants to three doses of group A Neisseria meningitidis polysaccharide vaccine administered at two, four, and six months of age.
    Gold R; Lepow ML; Goldschneider I; Draper TF; Gotschlich EC
    J Infect Dis; 1978 Dec; 138(6):731-5. PubMed ID: 105053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological effectiveness of a dried group-A meningococcal polysaccharide vaccine].
    Alliluev AP; Kotel'nikova OV; Chernyshova TF; Skirda TA; Kuvakina VI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Mar; (3):106-12. PubMed ID: 6428089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of children to Neisseria meningitidis polysaccharide vaccines.
    Monto AS; Brandt BL; Artenstein MS
    J Infect Dis; 1973 Apr; 127(4):394-400. PubMed ID: 4632878
    [No Abstract]   [Full Text] [Related]  

  • 5. Trial of a serogroup A meningococcus polysaccharide vaccine in Nigeria.
    Sanborn WR; Bencić Z; Cvjetanović B; Gotschlich EC; Pollock TM; Sippel JE
    Prog Immunobiol Stand; 1971; 5():497-505. PubMed ID: 4633977
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunogenicity of Hemophilus influenzae type B polysaccharide-Neisseria meningitidis group B outer membrane protein complex vaccine in infants and young children.
    Shapiro ED; Capobianco LA; Berg AT; Zitt MQ
    J Infect Dis; 1989 Dec; 160(6):1064-7. PubMed ID: 2511254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.
    Lepow ML; Goldschneider I; Gold R; Randolph M; Gotschlich EC
    Pediatrics; 1977 Nov; 60(5):673-80. PubMed ID: 411104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children.
    Gold R; Lepow ML; Goldschneider I; Draper TF; Gotshlich EC
    J Infect Dis; 1979 Nov; 140(5):690-7. PubMed ID: 118997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
    Peltola H; Mäkelä H; Käyhty H; Jousimies H; Herva E; Hällström K; Sivonen A; Renkonen OV; Pettay O; Karanko V; Ahvonen P; Sarna S
    N Engl J Med; 1977 Sep; 297(13):686-91. PubMed ID: 408682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysaccharide meningococcal vaccines--current status.
    Gold R
    Hosp Pract; 1979 Dec; 14(12):41-8. PubMed ID: 116953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who should be given meningococcal vaccine?
    Lancet; 1978 Dec; 2(8101):1185-6. PubMed ID: 82146
    [No Abstract]   [Full Text] [Related]  

  • 13. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.
    Lepow ML; Beeler J; Randolph M; Samuelson JS; Hankins WA
    J Infect Dis; 1986 Dec; 154(6):1033-6. PubMed ID: 3097160
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide.
    Peltola H; Käyhty H; Kuronen T; Haque N; Sarna S; Mäkelä PH
    J Pediatr; 1978 May; 92(5):818-22. PubMed ID: 417160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of meningococcal infection in the African meningitis belt by selective vaccination.
    Greenwood BM; Wali SS
    Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL; Wu X; Li MQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

  • 18. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.
    Twumasi PA; Kumah S; Leach A; O'Dempsey TJ; Ceesay SJ; Todd J; Broome CV; Carlone GM; Pais LB; Holder PK
    J Infect Dis; 1995 Mar; 171(3):632-8. PubMed ID: 7876610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).
    Parke JC; Schneerson R; Robbins JB; Schlesselman JJ
    J Infect Dis; 1977 Aug; 136 Suppl():S51-6. PubMed ID: 408433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Observations on the immune responses of infants and young children to group A meningococcal polysaccharide vaccine].
    Zhao JW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Feb; 4(1):12-4. PubMed ID: 6411345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.